Born in Munich, he first studied economics and graduated in business administration at the Ludwig-Maximilians-University in 1995. As he was involved with the stock market at a very early stage, he now has more than 30 years of experience in the capital markets. In the historic dot.com year 2000, he trained as a CEFA analyst in Frankfurt and has since then accompanied over 20 IPOs in Germany.
Until 2018, he held various positions at banks as an asset manager, capital market and macro expert as well as fundamental equity analyst. He is passionate about the energy, commodity and technology markets as well as the tactical and strategic asset allocation of liquid investment products. As an expert speaker at investment committee meetings of funds as well as at customer events, he can still describe the course of the 1987 crash, one of the major buying opportunities of the last 33 years on the stock market.
Today, he knows that the profit in shares is not necessarily the result of buying cheaply, but above all of avoiding mistakes and recognizing in good time when markets are ready to let air out. After all, in addition to basic fundamental analysis, investing in stocks is above all a phenomenon of global liquidity and this must be monitored regularly.
Commented by André Will-Laudien
Commented by André Will-Laudien on November 27th, 2024 | 07:00 CET
Biotech in focus! The 2025 blockbusters: Pfizer, BioNTech, Nyxoah, Valneva or Evotec - Who will take off?
The Q3 figures have now been processed. In the shadow of the tech giants on the Nasdaq, biotech stocks are currently being neglected. However, it is important to note that as pressure on the international economies increases, so does the likelihood of interest rate cuts by the central banks. Many investors have been underweight in biotech for quarters, prioritizing other sectors. All of this could be reversed in 2025. An early positioning with the most important protagonists seems promising. We are picking the best opportunities for you from the "Advent calendar."
Read
Commented by André Will-Laudien on November 26th, 2024 | 07:00 CET
Crypto & Bitcoin, the USD 100,000 madness – Will power shortages loom? Coinbase, Myriad Uranium, C3.ai and Palantir
The crypto madness continues! This week, Bitcoin enthusiasts are glued to their trading screens. Will the cryptocurrency break through the USD 100,000 barrier? Experts in the coin segment even consider price targets between USD 250,000 and 1 million conceivable. Anything is possible, as they say today. Meanwhile, market analysts are also noting the looming risks of power shortages. The extensive mining operations and the increasing use of artificial intelligence are consuming unprecedented amounts of electricity, demands not anticipated five years ago. Several countries have, therefore, decided to expand their nuclear power capacities, including France, Poland, Finland, the US and China. Conversely, Germany plans to stick to renewable energy sources - let's hope the sun starts shining at night soon. We explore these booming segments and seek opportunities for returns.
Read
Commented by André Will-Laudien on November 25th, 2024 | 07:00 CET
Takeovers – The 200% opportunities for 2025! Speculate now on the turnaround for Evotec, BioNxt, Bayer and Nel ASA!
The DAX 40 index is going from strength to strength, following the huge wave of buying since the US election. High-tech and defense stocks are leading the charge. Contrary to this positive trend, biotech stocks have so far been ignored. However, since interest rates are likely to be lowered for the foreseeable future due to the weakening economy, the time of the research-intensive life sciences industry will soon return. There are takeover rumors about Evotec. BioNxt is currently undervalued, and Bayer should be among the winners next year after successful restructuring efforts. It is worth taking a closer look.
Read
Commented by André Will-Laudien on November 21st, 2024 | 07:00 CET
Make Trump love hydrogen – why not? Nel, Plug Power, First Hydrogen, thyssenkrupp and nucera
- Even though Trump ignores or denies climate change, he has an advisory team focused on the future of the US. After all, the Republican Party wants to continue to govern even after the Donald era. However, the current election result is weighing on the entire green tech sector, so investors should selectively take advantage of the current sell-off. After all, the technologies will not disappear but continue to develop in the background. Hydrogen propulsion systems still play a niche role but could become more important due to technological advances and infrastructure investments. Their future depends heavily on how effectively renewable hydrogen can be produced and made available and how costs develop compared to other zero-emission technologies. First Hydrogen is demonstrating how the logistics and transportation sector could develop under the EU's "Net Zero 2050" target! Sentiment is low, so investors should switch in time to benefit from the impending rebound.
Commented by André Will-Laudien on November 20th, 2024 | 08:25 CET
Missiles for Russia! Returns lurk at thyssenkrupp, Rheinmetall, Almonty, Renk and Hensoldt?
Western missiles for Russia! A new escalation in the Ukraine conflict hits the trading floors of the stock markets, leading to significant losses for the DAX - dropping 400 points in just 24 hours. Portfolios now have to be quickly restructured as armaments are back in demand again. In addition, critical metals are also gaining traction because special elements such as tungsten are also needed to harden ammunition and military equipment. Those who pivot their portfolios swiftly could benefit from rapid revaluations.
Read
Commented by André Will-Laudien on November 19th, 2024 | 07:10 CET
Energy-guzzling artificial intelligence – Uranium in focus! Higher prices possible for Palantir, F3 Uranium, SAP and SMCI!
The energy demand is skyrocketing! Currently, high-tech companies from Silicon Valley are investing in power generators and uranium companies. This is because they will all need many times more electricity in the coming years than they do today in order to roll out their AI-driven business models. Artificial intelligence consumes, on average, 10 to 15 times more energy than conventional search engine queries. As a result, industry leaders are no longer willing to leave future energy supplies solely in the hands of governments, as the risk of supply disruptions appears too great. For several months, nuclear companies in the US have been developing so-called small modular reactors, while the EU wants to continue with renewable energies. Investors should weigh these options carefully, as these trends present significant opportunities for growth.
Read
Commented by André Will-Laudien on November 18th, 2024 | 07:10 CET
Uncertainty, volatility and BTC at USD 100,000? The stock checklist with BYD, VW, 123fahrschule and Mercedes
Donald Trump is moving back into the White House. Investors took the election result as an opportunity to stage a celebration on the US stock market. The major indices recorded a full 10% increase, and the US dollar strengthened significantly. Trump stands for fossil fuels, nuclear power and armaments. He dismisses climate change and the Paris Agreement and will not invest any further funds in the energy transition. This is a warning sign for the European economy because local governments are pursuing a "net zero" target for 2045, and their efforts are globally losing ground. High costs are squeezing the margins of local corporations, whereas US companies and Asian firms are doing brilliantly. For investors, there are many opportunities and timing is more important than ever. We have done the math.
Read
Commented by André Will-Laudien on November 14th, 2024 | 07:15 CET
The acquisition carousel is gaining momentum! Evotec, Vidac Pharma, BioNTech, and Formycon in focus
The biotech sector is in the spotlight again today. Triton's entry into Evotec means that another deal is in the works, and investors should now take notice. Many still remember MorphoSys, where there were short-term gains of up to 400% at the beginning of the year. Before that, the stock had been trading with high volumes. Will Formycon or Vidac Pharma be next on the list? Formycon is now getting significantly more attention because the stock switched to the Prime Standard. Evotec has once again disappointed operationally, yet the value has increased by a good 50% in just two months. Those who analyze carefully can profit again. A sharp analytical eye is worthwhile.
Read
Commented by André Will-Laudien on November 13th, 2024 | 07:30 CET
Gold correction - Now is the time to take advantage of the lows! Takeover rumors at Evotec, Desert Gold, Bayer and SMCI
The re-election of Donald Trump as US President had varying effects on the capital markets. The US dollar gained against all currencies, while the hot topic Bitcoin reached new all-time highs of over USD 90,000. The enormous influx of funds into the US stock markets initially slowed down other exchanges. At the same time, the previously sought-after precious metals corrected sharply, putting pressure on mining stocks again. The first shockwaves have now been absorbed, and attention is turning to the real political issues that the White House will now push forward. Defense, industry, and security are in the spotlight, while biotech and green tech remain sidelined. There are some interesting special movements that we will examine here.
Read
Commented by André Will-Laudien on November 12th, 2024 | 08:00 CET
Traffic light disaster brings new opportunities for e-mobility: VW, BMW, ARI Motors, BYD and NIO
The traffic light coalition has broken down – so right before left applies! In addition to the Berlin disaster, a relentless struggle has long since broken out in the automotive market. Habeck, for example, wants to get the environmental subsidy back in 2025 due to a sharp drop in electric vehicle sales, while important market shares of German industry have long since been lost. Germany is making only hesitant progress in the area of energy transition, while nuclear energy is experiencing a renaissance worldwide. Fortunately, innovative concepts are repeatedly emerging from medium-sized companies, driving Germany forward as a business location. With a new, forward-looking industrial policy, Germany could regain its leading position. For dynamic investors, this is an explosive environment with extraordinary opportunities for high returns.
Read